CRISPR Therapeutics Ownership | Who Owns CRISPR Therapeutics?
CRISPR Therapeutics Ownership Summary
CRISPR Therapeutics is owned by 83.05% institutional investors, 1.62% insiders, and 15.32% retail investors. Ark investment management is the largest institutional shareholder, holding 11.69% of CRSP shares. ARK Innovation ETF is the top mutual fund, with 8.63% of its assets in CRISPR Therapeutics shares.
CRSP Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | CRISPR Therapeutics | 83.05% | 1.62% | 15.32% |
| Sector | Healthcare Stocks | 486.50% | 11.08% | -397.59% |
| Industry | Biotech Stocks | 304.14% | 11.08% | -215.23% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ark investment management | 10.18M | 11.69% | $495.28M |
| Blackrock funding, inc. /de | 6.07M | 6.97% | $295.07M |
| Capital investors | 5.59M | 6.42% | $272.08M |
| T. rowe price investment management | 3.68M | 4.23% | $179.14M |
| Blackrock | 2.78M | 3.40% | $150.03M |
| Sumitomo mitsui trust | 2.75M | 3.22% | $108.07M |
| Orbis allan gray | 2.76M | 3.18% | $134.47M |
| State street | 2.49M | 2.95% | $98.07M |
| Nikko asset management americas | 2.41M | 2.77% | $117.38M |
| Fmr | 2.22M | 2.61% | $87.51M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Versant venture management | 498.56K | 29.52% | $24.25M |
| Sr one capital management, lp | 1.05M | 10.07% | $41.29M |
| Spear rsc | 165.00K | 6.29% | $8.91M |
| Nea management company | 1.59M | 5.81% | $77.23M |
| Ark investment management | 10.18M | 3.63% | $495.28M |
| Green alpha advisors | 58.46K | 2.72% | $2.84M |
| Contrarius investment management | 685.72K | 2.32% | $37.04M |
| Ecor1 capital | 1.39M | 2.07% | $54.68M |
| Eagle health investments lp | 197.00K | 1.87% | $10.64M |
| Nikko asset management americas | 2.41M | 1.17% | $117.38M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 6.07M | 0.01% | 3.45M |
| Ubs group | 1.98M | 0.01% | 1.31M |
| Orbis allan gray | 2.76M | 0.65% | 1.20M |
| National bank of canada /fi/ | 735.60K | 0.03% | 735.60K |
| Millennium management | 583.73K | 0.01% | 575.24K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Baker bros. advisors lp | - | - | -654.10K |
| Bellevue group | - | - | -610.00K |
| Farallon capital management | - | - | -530.00K |
| State street | 2.49M | 0.00% | -501.46K |
| Morgan stanley | 597.68K | 0.00% | -488.25K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| National bank of canada /fi/ | 735.60K | 0.03% | 735.60K | $35.78M |
| Norges bank | 443.54K | 0.00% | 443.54K | $17.46M |
| Mcelhenny sheffield capital management | 136.00K | 0.03% | 136.00K | $129.17K |
| Philadelphia trust | 50.25K | 0.19% | 50.25K | $2.44M |
| Palo alto investors lp | 44.63K | 0.46% | 44.63K | $2.17M |
Sold Out
| Holder | Change |
|---|---|
| Impact partnership wealth | -1.00 |
| Activest wealth management | -1.00 |
| Frazier financial advisors | -2.00 |
| Toronto dominion bank | -4.00 |
| Baldwin brothers llc/ma | -4.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 457 | 9.33% | 72,312,350 | 12.69% | 83 | 1.49% | 228 | 31.03% | 101 | -2.88% |
| Mar 31, 2025 | 16 | -96.30% | 3,317,986 | -94.86% | 3 | 0.07% | 8 | -95.58% | 3 | -97.52% |
| Dec 31, 2024 | 420 | -5.83% | 64,513,268 | 8.48% | 76 | 1.57% | 174 | - | 118 | -10.61% |
| Sep 30, 2024 | 437 | -9.15% | 59,424,788 | -0.24% | 69 | 1.31% | 167 | -19.71% | 131 | 1.55% |
| Jun 30, 2024 | 478 | -7.54% | 59,547,600 | 1.78% | 72 | 1.42% | 205 | -12.02% | 129 | -9.15% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Innovation ETF | 7.63M | 8.63% | 724.51K |
| ARK Disruptive Innovation Full Composite | 7.04M | 7.97% | -136.93K |
| Capital Group New Perspective Comp | 2.15M | 2.49% | -406.93K |
| American Funds New Perspective A | 2.15M | 2.49% | -406.93K |
| ARK Genomic Revolution | 2.06M | 2.33% | -35.46K |
| ARK Genomic Revolution ETF | 1.94M | 2.24% | -11.63K |
| iShares Russell 2000 ETF | 1.95M | 2.21% | -37.06K |
| American Funds SMALLCAP World A | 1.65M | 1.91% | - |
| T. Rowe Price US Mid-Cap Growth Equity | 1.49M | 1.73% | -1.60K |
| T. Rowe Price Mid-Cap Growth | 1.49M | 1.73% | -1.10K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 18, 2025 | Kulkarni Samarth | Chief Executive Officer | Sell | $760.66K |
| Aug 06, 2025 | Treco Douglas A | - | Buy | $1.14M |
| Jul 16, 2025 | George Simeon | - | Buy | $1.16M |
| Jul 16, 2025 | George Simeon | - | Buy | $338.72K |
| Jul 16, 2025 | George Simeon | - | Buy | $50.00M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | 4 | 1 |
| 2025 Q2 | - | 1 |
| 2025 Q1 | 1 | 17 |
| 2024 Q4 | - | 5 |
| 2024 Q3 | - | - |
CRSP Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools